Antibody-Mediated Inhibition of Insulin-Degrading Enzyme Improves Insulin Activity in a Diabetic Mouse Model

Diabetes is a metabolic disease that may lead to different life-threatening complications. While insulin constitutes a beneficial treatment, its use may be limited due to increased degradation and an increase in side effects such as weight gain and hypoglycemia. Small molecule inhibitors to insulin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fursht, Ofir, Liran, Mirit, Nash, Yuval, Medala, Vijay Krishna, Ini, Dor, Royal, Tabitha Grace, Goldsmith, Guy, Nahary, Limor, Benhar, Itai, Frenkel, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958001/
https://www.ncbi.nlm.nih.gov/pubmed/35350789
http://dx.doi.org/10.3389/fimmu.2022.835774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958001/
https://www.ncbi.nlm.nih.gov/pubmed/35350789
http://dx.doi.org/10.3389/fimmu.2022.835774

Ejemplares similares